COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Patients:
- People aged 18 or older
- People who have previously been diagnosed with asthma or chronic obstructive pulmonary disease (COPD), confirmed using recognised international diagnostic guidelines
- People who are able to cooperate and participate in the trial
- People who have had no flare-ups or worsening of their condition for at least 8 weeks
- People who have been using a specific type of inhaler for at least 3 months
- People who have signed a consent form agreeing to take part
Healthcare professionals:
- People who have completed education in medicine, pharmacy, or nursing
- People with more than one year of working experience in their field
- People who care for patients using inhaled treatments for asthma or COPD
- People who have signed a consent form agreeing to take part
Who may not be able to join:
Patients:
- People who are in the final stages of any serious illness
- People who are unable to cooperate or participate in the trial
- People who have significant difficulties with movement or thinking and memory
Important: Always verify eligibility with the trial site directly before applying.
Note: This trial appears to involve both patients and healthcare professionals as separate participant groups. The trial site can confirm which group applies to a given situation and what the specific inhaler requirement refers to (confirm with trial site).
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 00420 495 067 421
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Adherence to inhaled treatment measured by Five Steps Assessment (FSA).; Adherence to inhaled treatment measured by the Medication Adherence Report Scale (MARS).; Critical knowledge measured by our own questionnaire in healthcare professionals caring for patients with COPD and bronchial asthma.; Critical skills related to inhalation techniques measured by FSA in healthcare professionals caring for patients with COPD and bronchial asthma.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.